Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
3
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Dr. Mohammad Haji Aghajani Chancellor of Shahid Beheshti University of Medical Sciences
In the name of GOD Dear attendances For the past fourteen years, the Cancer Research Center of the Shahid Beheshti University of Medical Sciences has undertaken scientific and practical deepening of cancer-related sciences and has not denied any effort. Fourteen years is such a long years that needs a great deal as a backbone. Four years ago another congress has been added to cover all of the cancers. I am honored to welcome you to these two congresses and have the hope of accepting this presentation from Shahid Beheshti University of Medical Sciences. Today, the incidence of cancers and the amount of cancer associates has increased, and our country and the province of Tehran are no exception of these rates. Shahid Beheshti University of Medical Sciences, which has the majority of individuals in Tehran, has a new face in the process of cancer. Cancers which associate with infectious agents such as cervical and stomach cancers is declining, and cancers which associated with social and Lifestyle quality, such as breast and prostate, is on the increase. Knowing the exact changes in the incidence of cancers in the area which covered by the university and the way of care of them is one of the effective factors in providing more scientific services to the people. Reports from the Cancer Research Center indicate a significant reduction in the deaths of cancer patients in spite of their increased incidence, and this component is an important indicator of secondary and tertiary evaluation and prevention, which our university is proud to be point of this assessment. Cancer has created a prominent situation among the most advanced countries of the world and Islamic republic of Iran, with a totally different power among the non-communicable diseases, and we need to vigorously regulate and control these changes. I hope the 14th International Breast Cancer Congress and the 4th International Gastrointestinal Cancer congress will succeed for this servicing through people.
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran4
Prof. Mohmmad Esmaiel Akbari Chairman
Head of Cancer Research Center, Head of 14th International Breast Cancer Congress
Head of 4th International Gastrointestinal Cancer Congress
In the name of GOD
Dear professors and attendances, Thanks God for succeeded of Cancer Research Center of Shahid Beheshti University of Medical Sciences in serving education to the community of medicine for the 14th years of breast cancer and 4th years of gastrointestinal cancer congresses. This year, we are proud to announce that the Cancer Research Center, with its 27 years report on breast cancer care, was able to publicize its brilliant results. In this article the 10 years and 5 years overall survival rate for young people under the age of 40 and over 40 years old reported as 80% and 91% respectively. And this proud relates to the all of the colleagues at the Cancer Research Center, who make this rate as equivalent to or better than the world's most advanced countries, especially at higher clinical levels. Our study showed that breast preservation is not only a standard scientific method of surgery, but also it increases the longevity and overall survival rate of the disease. And this issue is an emphasis on our tries during the past thirty years. In the case of gastrointestinal cancers, it is also a great honor for our country that the death record for the period from 2005 to 2014 decreased from about 82% to 30%, and this indicator is comparable to advanced countries. Our 5 years report from patients who treated with Intra Operative Radiotherapy (IORT), either in the form of boost or radical doses, was an emphasis on this very hard work of the Cancer Research Center, which shows a clear future for this therapeutic approach in Iran to all associates. This year, we succeeded in encouraging the launch of a biopsy of the lymph nodes (SLNB) after 13 years of effort to greatly expand this scientific method and make patients happy. This year, in collaboration with international organizations, we published dozens of major articles in the world, and dozens of other papers are being finalized, which will cover the appearance and care of cancers in Iran, including 5 articles in the Lancet 2018 that was published in number 392. At congresses this year, we are trying to use the expertise of both national and international scientists to expose the goals of our research to public judgment. All of our wishes are your satisfaction with those who are attending these congresses, and which gives us encouragement. Hope GOD and you will be satisfied with us. Successes of these ongoing congresses achieved because of dear respected prof. Mirzaei, the scientific secretory of 14th IBCC, and prof. Moradi, the scientific secretary of 4th IGICC. Absolutely they created an amazing meeting with using the previous experiences, knowledge and compassion. Of course, the situation of all my great colleagues in the executive branch at the Cancer Research Center and these two congresses is prominent. I also sincerely thank to them too.
5
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Prof. Hamid Reza Mirzaei Scientific Secretary
Of The 14th International Breast Cancer Congress
In The Name Of God
Thanks GOD for the successful holding of the International Congress Regarding breast cancer. It gives me great pleasure to welcome you to 14th International Breast Cancer Congress of Iran (IBCC 2019). We are proudly home to some of the best and brightest medical minds who are leading the way in revolutionary discoveries that will save lives.The plan establishes long-term goals to prevent breast cancer, improve the experience of the cancer treatment,care system and increase survival. We know that a diagnosis of breast cancer can be challenging for the patient, their family, their friends and their community.This Congress brings together world leading experts to discuss current issues in breast disease including surgery, radio oncology, pathology,molecullar & genetic issues, breast radiology, IORT and early diagnosis will be discussed. I encourage you all to use this event as an opportunity to share ideas and strengthen international relationships to effectively address clinical and therapeutic problems in breast disease. This event is the result of worthy effort of scholarly and sympathetic members of the scientific and executive committees and my colleagues of cancer research center over the years.
Yours sincerely
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran6
Afshin Moradi Scientific Secretary
Of The 4th International Cancer Congress
In The Name Of God
Dear Colleagues, It is my great pleasure to welcome you on behalf of the International Conference on Gastrointestinal Cancers Organizing Committee, and to invite you to attend the International Conference on Gastrointestinal Cancers to be hosted in Tehran, Iran, 2019. This conference goes to the heart of all matters relating to gastrointestinal malignancies, and it brings together the best scientists from around the world allowing you to hear and meet those at the forefront of our practice, and is being held in an amazing location, SBMU School of Nursing and Midwifery. There will be delegates not only from Iran, but from the Europe and North America. Distinguished speakers will provide the most up-to-date reviews from liver, pancreas, stomach, and colorectal malignancies. The Gastrointestinal Cancers Congress 2019 should end with some strong take-home messages. To reach that goal we need multiple sources of evidence and different clinical experiences. We need your work to be shared. The Gastrointestinal Cancers 2019 Conference is a unique and unmissable opportunity to meet face to face with colleagues from different parts of the world. It is a major contribution for the development and consilience of knowledge. We look forward to welcoming you in Tehran, Iran. We hope you will join us to make The 2019 congress on The Gastrointestinal Cancers a memorable event!
7
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Dr. Mohammad Hadizadeh Executive Secretary
In the name of GOD
Dear professors,Another year pasts and again we are attending in this ongoing International Breast Cancer Congress. The prominent result of previous congresses was promoting the development of space science and researches about care of patients with breast cancer in Iran. AS the breast cancer is the most common cancer among women and has a low incidence in men, it accounts also as one of the most important goals and focus areas in health systems. The average age of diagnosis among Iranian women is 45 to 55 years of age compared to other Western countries that is about ten years younger. Since early detection of breast cancer is directly linked with increased awareness, it can be a key component in the prevention and improvement the quality of the treatment. Now, after a year of holding the International Breast Cancer Congress, academic and administrative activities of the Congress have been completed. I, as the executive secretary of the 14th International Breast Cancer Congress have thanks and gratitude from the executive team for their unwavering cooperation. Their cooperation and tireless efforts make to alert the experts and access to updated scientific information. I hope that the experiences which gained from the former Congresses at Cancer Research Center of Shahid Beheshti University of Medical Sciences will also be held more fruitful of presented congress and these efforts will lead to the promotion of health.
Yours Sincerely,
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran8
Congress Organization
Executive CommitteeExecutive Director:
Maryam Karami
Responsible for International Relations: Dr. Narjes Mehrvar, Dr. Sanaz Tabarestani
Somayeh Zoghi pour Hosna Akbari Hossein Akbari Zeynab Aliee Seyed Mehdi Barazi Azam Bazarpour Reza Esbati Dr. Reyhaneh Gharehgozlou Sajedeh Alimohammadi Dr. Shiva Ghasemi Farhad Moshfegh
Prof. Mohmmad Esmaiel Akbari Chairman
of The 14th International Breast Cancer Congress & 4th International Cancer Congress
Dr. Hamidreza Mirzaei Scientific Secretary
of The 14th International Breast Cancer Congress
Dr. Mohammad Hadizadeh
Executive Secretary of The 14th International Breast Cancer Congress
& 4th International Cancer Congress
Afshin Moradi Scientific Secretary
of The 4th International Cancer Congress
9
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Mirmusa Rashidosadat Narges Saberian
Organizer Cancer Research Center- Shahid Beheshti University of Medical Sciences
Colleagues Ministry of Health and Medical Education Cancer Research Centers of Universities of Medical Sciences Islamic Azad University Tehran Medical Branch Universities of Medical Sciences across Iran
APOCP Medical Council of the Islamic Republic of Iran Iranian Scientific Association of General Surgeon International society Intraoperative Radiation Therapy (ISIORT) Iranian Society of Radiation Oncology Iranian Scientific Association of Hematology and Oncology Iranian Society of Pathology
EURAMA Iranian Society of Radiology Iranian Nursing Scientific Association
EUSOMA Iranian Medical Education Scientific Association Charity Foundation for Special Diseases World Health Organization (WHO) European Institute of Oncology (EIO) United Nations Population Fund (UNFPA( St.Gallen Keynote Speakers from Iran, England, Italy, Australia, Iraq, Germany,
Qatar, Pakistan, …
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
10
14th International Breast Cancer Congress
Scientific Committee
Epidemiology and Social Medicine Dr.M.Mohseni Dr.AR.Mousavi Jarrahi Dr.H.Souri Dr.P.Yavari Dr.F.Zayeri
Dr.M.Asadi Lari Dr.A.Bahadori Dr.PH.Davis Dr.SH.Haghighat Dr.M.Khayam Zadeh (Director)
Nuclear Medicine Dr.R.Sadeghi Dr.MK.Shiroudi
Dr.M.Amouei (Director) Dr.M.Rafeiei Zadeh Dr.GH.Razei
Surgery Dr.M.Habibi (USA) Dr.Hadis (USA) Dr.M.Hadizadeh Dr.I.Harirchi Dr.E.Hashemi Dr.S.Hashemi Dr.M.Heydari Dr.R.Hiltebrand (Swiss) Dr.A.Hojat Dr.S.J.Hosseini Dr.M.Intra (Italy) Dr.N.Jadalizadeh Dr.MR.Javadi Dr.A.Joulaei Dr.MR.Kalantar Motamed Dr.A.Kaviani Dr.M.Khoramshahi Dr.A.Khoshkar Dr.J.Khoshnevis Dr.H.Mahmoud Zade Dr.K.Markopolous (Greece) Dr.N.Mansour Moshtaghi Dr.F.Meybodi (Australia) Dr.MR.Mir Dr.A.Mirmalek Dr.H.Moayeri Dr.N.Moeini Dr.A.Mojallal (France)
Prof.M.E.Akbari (Director) Dr.F.Abasvandi Dr.A.Abdollahi Dr.S.Alipour Dr.A.Afsharfard Dr.TMJ.AL – Lawati (Oman) Dr.J.Akbari Dr.M.Akhgari Dr.M.Akrami Dr.H.Almasi Dr.M.Ariana Dr.M.Asadi Dr.L .Asef Kabiri Dr.M.Atri Dr.KH.Ayazi Dr.P.Aziminejadan Dr.J.Benson (England) Dr.M.Bohlooli Dr.M.J.Cardoso (Italy) Dr.P.Daryani Dr.M.Davaei Dr.W.C.Dooley (USA) Dr.K.Dowlatshahi(USA) Dr.M.Ebrahimi Dr.F.Ebrahimfar Dr.ZH.Farhadi (Switzerland) Dr.MN.Forghani Dr.F.Golfam
11
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Dr.F.Moradian Dr.SR.Mousavi Dr.M.Samsami Dr.S.Sayad Dr.S.Sayad Dr.S.Sehhat Dr.A.Seifi Dr.M.Shafahi Dr.J.Shakeri Dr.L.Shojaei Dr.F.Sirati Dr.Stefano Pompei (Italy) Dr.N.Tadayon Dr.F.Tavakoli Dr.A.Vahedi Dr.A.Yazdankhah Dr.R.Yeganeh Dr.MR.Zafarghandi Dr.AR.Zali Dr.F.Ziaei Dr.S.Zorrida (Italy)
Dr.B.Gol Oghlu (Turkey) Dr.R.Mousavi Dr.SM.Mousavi Naeini Dr.S.Motamed Dr.M.Motamedi Dr.M.Mozaffar Dr.M.Nabat Zadeh Golshan Dr.N.Nafisi Dr.M.Najafi Dr.M.Nava (Italy) Dr.F.Nazemian Dr.A.Olfatbakhsh Dr.R.Omranipour Dr.J.Peti (Italy) Dr.H.Peyvandi Dr.SM.Rabiei Hashemi Dr.B.Rahmani Dr.A.Razmavar Dr.J.Remi Garbi (France) Dr.KH.Rostami Dr.A.Rouyintan Dr.A.Salati
Psychology and Psychiatry Dr.S.Omidvari Dr.Patricia Fobeir (USA) Dr.SH.Vaziri
Dr.N.Beyraghi Dr.M.Firouzi Dr.T.Kermani Ranjbar (Director) Dr.F.Lotfi Kashani
Radiology Dr.J.Jalal Shokoohi Dr.M.Kalantari Dr.N.Kamangari (England) Dr.MH.Kharazi Dr.Z.Mahboubi Fouladi Dr.M.Nouri Dr.S.Sabouri Dr.M.Sanei Taheri Dr.N.Sedighi
Dr.F.Ahmadi Dr.N.Ahmadinejad Dr.A.Ameri Dr.Astani Dr.KH.Bakhtavar Dr.N.Behboudi Moghaddam Dr.SH.Dadgari Dr.M.Giti Dr.HR.Haghighatkhah (Director) Dr.D.Hendesi
Radiation Oncology Dr.M.Malekzadeh Moghani Dr.G.Mazdaei Dr.H.R.Mirzaei(Director) Dr.A.Moghadam Dr.I.GH.Mohammed(canada)
Dr.S.Almasi Dr.A.Ameri Dr.R.Anbiaei Dr.F.Andre(France) Dr.AM.Aref Pour
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
12
Dr.Mosalaei Dr.MA.Mousavi Zadeh Dr.H.Nasrolahi Dr.A.Nikou Far Dr.R.Orecchia(Italy) Dr.M.Picard Dr.A.Rakhsha Dr.S.Saedi Dr.R.Salek Dr.S.Salmanian Dr.M.Sanei Dr.M.Sardari Dr.M.Savad Kouhi Dr.H.Shahbazian Dr.G.Steger(Austria) Dr.SM.Tabatabeifar Dr.T.Taheri Panah Dr.M.Tajvidi Dr.F.Taslimi Dr.A.Yaghoubi Dr.SH.Yahyazadeh Dr.A.SH.Yousefi Kashi Dr.J.Zi (Netherlands)
Dr.F.Asrari(USA) Dr.S.Atrchian(canada) Dr.P.Azadeh Dr.S.Azghandi Prof.F.A.Calvo(Spain) Dr.G.Festner(Netherlands) Dr.H.Foudazi Dr.A.Ghanbari Motlagh Dr.MR.Ghavamnasiri Dr.P.Gorji Bayani Dr.P.Haddad Dr.K.Hadis(USA) Dr.P.Hajian Dr.S.Hemati Dr.S.Hemmati Dr.Hogo Raul Marsiglia (Italy) Dr.F.Homaei Dr.M.Houshiari Dr.A.Jafari Dr.SH.Kamian Dr.S.Loibl(Germany) Dr.A.Mafi Dr.Y.Makhdoumi
Obstetrics and Gynecology Dr.A.Akbari (Director) Dr.R.Alami Harandi Dr.M.Bahman Pour Dr.M.Hoseini
Dr.A.Abdalhafzi(Egypt) Dr.M.Afrakhte Dr.A.Aghazade Naeini Dr.L.Ajori
Genetic Dr.H.Najm Abadi Dr.E.Noushinfar Dr.M.Nowrouzi Niya Dr.N.Parsa Dr.M.Pornour DR.G.Somliai(Hungary) Dr.S.Tabarestani (Director) Dr.A.Taghavi Dr.VR.Yasaei Dr.H.Zali
Dr.GH.Ahangari Dr.MA.Faghihi(USA) Dr.R.Gharehgozlou Dr.M.Hashemi Dr.SH.Hodgson(USA) Dr.T.Langaei(USA) Dr.K.Majidzadeh Dr.P.Mehdipour Dr.S.H.Moghadam Niya Dr.S.Mohammad Pour Dr.A.Movafagh
13
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
Physical medicine and rehabilitation Dr.D.Eliaspour Dr.SM.Raygani (Director)
Dr.Angouti Ashnari Dr.MH.Bahrami
Medical Physics Dr.SR.Mahdavi (Director) Dr.A.Mostaar Dr.M.Shahani
Dr.MR.Aghamiri Dr.M.Bakhshande Dr.SH.Ghasemi Dr.M.Hosseini Daghigh
Hematology Oncology Dr.M.Khani Dr.A.Moghaddam Dr.M.Mojtabavi Naeini Dr.F.Mokarian Dr.D.Monadi Zadeh Dr.S.Najafi Dr.AA.Nejati Safa Dr.M.Razavi Dr.H.Rezvani Dr.N.Rostami Dr.T.Ruhstaller(swiss) Dr.R.Shahsavani Dr.J.Shams Dr.M.Tabaraei Dr.M.Vakili
Dr.M.M.Adib Sereshki Dr.H.Attarian Dr.S.Azambuja(Portugal) Dr.CH.Coumbes Dr.G.Curigliano(Italy) Dr.M.Ehsani Dr.F.Elahi Dr.F.Esfahani(Director) Dr.M.Ghadiani Dr.A.Ghavam Zadeh Dr.A.Haj Fathali Dr.M.Jahani Dr.H.Jalaei Khou Dr.GH.Jan Babaei Dr.M.Keyhani
Pathology and Laboratory Dr.M.Hoseyni
Dr.P.Hoseyn PourDr. Jahan Bin Dr.S.A.Mir Afshariyeh Dr.A.Nosrati Dr.H.Zham
Dr.A.Moradi (Director) Dr.M.Ahadi Dr.H.Boroumand Dr.A.Dehghan Dr.A.Eftekhari Dr.S.M.Eftekhari Dr.O.Emami Al Agha Dr.M.Gharib
Dr.H.Haji Zade Fallah
Health sciences Dr.A.Nourouzi Dr.Mouhebati
Dr.MR.Vaez Mahdavi Dr..A.Akbari Dr.M.Akbari
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
14
Nutritionist Dr.AM.Mortazavian Dr.Z.Nourollahi Dr.Sohrabvand Dr.MR.Vafa
Dr.S.H.Davoudi (Director) Dr.Doaei Dr.S.Esmaeili Dr.Gholamalizadeh
Traditinal medicine and Geriatrics Dr.N.Rezaei Pour Dr.H.Rezaei Zadeh(Director)
Dr.G.Heydari Dr.Mazrae Shahi Dr.A.Nowrouzi
Immonology Dr.S.Namaki
Mechanical and Aerospace Engineering Dr.M.Ebrahimi
Pediatrics Dr.R.Kelishadi Dr.KH.Rahmani
Immono Oncology Dr.S.Dermime (Qatar)
Midwifery and Nursing Dr.N.Khodakarami (Director) Dr.G.Mohammadi Dr.F.Nahidi Dr.M.Rasouli Dr.M.Simbar Dr.Zeynali
Dr.A.Abbas Zadeh Dr.F.Atash Zadeh Dr.F.Borhani Dr.M.Dolatian Dr.S.Hajian Dr.M.Ilkhani Dr.Z. Keshavarz
Electrotechnical Surgery Dr. M.Abdolahad
15
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
4th International Cancer Congress
Scientific Committee
Surgery Dr. F Moradian Dr. N Mansour Moshtaghi Dr. S R Mousavi Dr. M Mozafar Dr. H Nemati Dr. S Nikeghbalian Dr. M Samsami Dr. J Shakeri Dr. K Tulabi Dr. MR Zafarghandi Dr. H R Zamani
Prof.M.E.Akbari Dr. A Afshar fard Dr. F S Anaraki Dr. M Dehghan Dr. M S fazeli Dr. B Ghavami Dr.I.Harirchi Dr. M R Kalantarmotamedi Dr. J Khoshnevis Dr. R Kianmanesh Prof. SA Malek Hoseini
Radiology Dr. S A Astani Dr. P Dehghan H R Haghighatkhah Dr. M Saneitaheri
Radiation Oncology Dr. M Boroumand Dr. A Ghanbari Motlagh Dr. M Houshiary Dr. A Mafi Dr. H R Mirzaei Dr. M Sanei Dr. A yaghubi juibari
Genetic Dr. A Taghavi Dr. S Tabarestani
Hematology Oncology Dr.GH.Jan Babaei H Rezvani
14th International Breast Cancer Congress & 4th International GI Cancer Congress
20-22 Feb 2019, Tehran. Iran
16
Pathology and Laboratory Dr. F Bidari Dr. H Hajizadeh fallah D r. S Hafezi Bakhtiari Dr.P.Hosseinpour Dr. Z Kamali Dr. B Kazeminejad Dr. A Moradi (Director) Dr. M Saberafsharian Dr. SH Sabeti
Nutritionist Dr. S H Davoodi Dr. S Doaei Miss M Gholamalizaeh Dr. N Khoshnevis Dr. T Rezanistani Dr. M Shadnoush
Health sciences Dr.M Akbari Dr.T Mouhebati Dr. A.Norouzi Dr.MR Vaez Mahdavi
Epidemiology and Social Medicine Dr.SH.Haghighat Dr.H.Souri
Immonology Dr.S.Namaki
Gastroenterology Dr. S Abdi Dr. M Forutan Dr. R Malekzadeh Dr. A Sadeghi Dr. B Salehi Dr. SH Shahrokh Dr. N Zendehdel
Electrotechnical Surgery Dr. M Abdolahad
17
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
14th International
Breast Cancer Congress 20-22 Feb / Tehran / Iran
18 18
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
19
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Scientific Program
14th International Breast Cancer Congress
20 20
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Day 1: Wednesday 20 Feb 2019 Time Title Speaker
8:30 – 8:40 National Anthem & Recitation of Holy Quran
8:40 – 9:10 Scientific Secretary of Congress Dr.H.R.Mirzaei
9:10 – 9:30 President of Congress Dr.M.E.Akbari
Chairmen:
Dr.S.Sehhat, Dr.A.A.Ameri, Dr.M.Sardari, Dr.M.A.Mousavi Zadeh, Dr.M.Shafahi, Dr.M.Atri
9:30 - 10 Fertility issues in breast cancer
patients/Breast Cancer during pregnancy
Prof.S.Loibl
(Clinical Oncologist -
Germany)
10 – 10:30 Immune Checkpoint Inhibitors in Breast
Cancer: the PD-L1/PD-1 Story
Prof.S.Dermime
(Imono Oncologist -
Qatar)
10:30 - 11 Break
11 – 12:30
Panel discussion: What should we do in a patient with positive
sentinel lymph node?
Coordinator: Dr.M.Hadi Zadeh
Members: Dr.M.Rabie Hashemi, Dr.P.Azade, Dr.A.Mirmalek,
Dr.O.Emami Alagha, Dr.A.Astani, Dr.S.Azghandi,
Dr.S.Hashemi, Dr.SH.Razavi, Dr.M.Ghadiani, Dr.M.Amouie
12:30 – 13:30 The Prayer and Lunch
Chairmen: Dr.R.Mousavi, Dr.P.Daryani, Dr.H.Mahmoudzade,
Dr.R.Omrani Pour, Dr.A.Khoshkar, Dr.H.Mokarian
13:30 – 14 Management of the axilla Prof.J.Benson
(Surgeon – England)
14 – 14:30
Radiomics and radiogenomics in breast
cancer. A great opportunity to personalize
the radiation treatment
Prof.R.Orecchia
(Radiation Oncologist
– Italy)
14:30 – 14:45 Cancer Diagnostic Prob (CDP) in detection of
suspicious margin in breast cancer cases
Dr.Abdol Ahad
(Electrotechnical
Sergeon– Iran)
14:45 – 16:15
Panel discussion: BCS and MRM: what about overall survival and recurrence?
Coordinator: Dr.M.Mozafar
Members: Dr.A.Abdollahi, Dr.Z.Mahboubi Fuladi, Dr.M.Malek Zade,
Dr.A.Nosrati, Dr.M.Khayam Zade, Dr.L.Shojaei, Dr.N.Moeini,
Dr.H.Yahyazade, Dr.S.Najafi, Dr. S.Tabarestani
21
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Chairmen:
Dr.M.Jadalizade, Dr.F.Sirati, Dr.M.Mousavi Naeini, Dr.H.Peyvandi, Dr.S.Salmaniyan,
Dr.H.Foudazi, Dr.H.Jalaei Khou
16:15 – 16:30
Organs at Risk Dosimetry During
Low Energy
X-Ray Breast IORT
Dr.S.M.Hoseini Daghigh
(Medical Physics – Iran)
16:30 – 16:45
Gene expression profile of
circulating tumor cells in breast
cancer by RT-q PCR
Dr.A.Gharibi
(Genetics – Iran)
16:45 - 17
The Relationship between A245 T
Polymorphism of leptin gene and
breast cancer in women in Urmia
Dr.M.Hakimian
(Genetics – Iran)
22 22
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Day 2:Thursday 21 Feb 2019
TimeTitleSpeaker
8 – 9:30
Panel discussion: Practical solutions to reduce the financial burden
of cancer
Coordinator: Prof.M.E.Akbari
Members: Dr.I.Harirchi, Dr.GH.Jan Babaei, Dr.M.R.Vaez Mahdavi,
Dr.A.Ghanbari Motlagh, Dr.M.R.Zafarghandi, Dr.SH.Haghighat,
Dr.P.Hosseinpour, Dr.M.Akbari, Dr. A.Norouzi, Dr.A.Moradi,
Dr.H.Souri, Dr.T.Mouhebati
9:30 – 9:45 Welcoming Message
Prof. M.E Akbari
(head of cancer research
center and congresses)
9:45-10:00 Opening Notes
Dr. S Namaki
(Minister of Health and
Medical Education)
10:00-10:30 Appreciation of Honorable Prof. S A Malek Hoseini
10:30 - 11 Break
Chairmen:
Dr.S.Sehhat, Dr.M.Khoramshahi, Dr.A.Nikoufar, Dr.M.R.Ghavamnasiri,
Dr.H.Almasi, Dr.S.Hemeti, Dr.H.Yahya Zade, Dr.H.Shahbazian,
Dr.R.Mousavi, Dr.H.Atarian
11 – 11:30 Management of triple negative breast
cancer
Prof.G.Steger
(Clinical Oncologist – Austria)
11:30 - 12
Current indications in the
management of the axilla. The role of
radiation therapy
Prof.R.Orecchia
(Radiation Oncologist – Italy)
12 – 12:30 Surgical treatment of multiple
ipsilateral breast cancers
Prof.J.Benson
(Surgeon – England)
12:30 – 13:10 The Prayer and Lunch
13:10 – 13:30
Targeting breast cancer through
aromatase inhibition: a
biotechnological approach
Prof.A.T.Wahab
(Molecular Medicine –
Pakistan)
13:30 - 14 Advances in breast cancer
management
Prof.G.Steger
(Clinical Oncologist – Austria)
23
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
14 – 15:30
Panel discussion: IORT in moderate risk B.C (cautionary group)
Coordinator: Dr.R.Salek
Members: Dr.N.Forghani, Dr.R.Mahdavi, Dr.M.Ahadi, Dr.F.Abas Vandi,
Dr.M.R.Javadi, Dr.N.Ahmadi Nejad, Dr.F.Tavakoli, Dr.H.Nasrollahi
Dr.M.Savad Kouhi
Chairmen:
Dr.S.Almasi, Dr.S.Alipour, Dr.A.Vahedi, Dr.A.Razmavar, Dr.M.Sanei,
Dr.A.M.Aref Pour
15:30 - 16
New treatment
New evolvement in HER2+ breast
cancer
Prof.S.Loibl
(Clinical Oncologist -
Germany)
16 – 16:15
Investigation the incidence of breast
cancer among women in Hormozgan
in 2015
Dr.N.Roozbeh
(Medical Physics – Iran)
16:15 – 16:30
Male breast cancer in patients
referred to radiation oncology
centers of Mashhad University of
Medical Sciences from 1991 - 2012
Dr.M.Nouri
( Iran)
24 24
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Day 3: Friday, 22 Feb 2019
Time Title Speaker
Chairmen:
Dr.M.R.Mir, Dr.N.Khodakarami, Dr.J.Akbari, Dr.M.Ebrahimi, Dr.B.Rahmani,
Dr.A.Ghavam Zade, Dr.A.Kaviani, Dr.R.Shahsavani
8:30 – 8:45 Assessment of Risk Factors of Breast
Cancer in Al-Najaf Province
Dr.A.Al-fahham
(Iraq)
8:45 – 9:15
Downregulation of the cell surface
PD-L1 and its upregulation in the
nucleus of breast cancer cells by
Doxorubicin treatment
Prof.S.Dermime
(Imono Oncologist - Qatar)
9:15 – 9:45 Locally advanced breast cancer-
surgical aspects
Prof.J.Benson
(Surgeon – England)
9:45 – 10:15 Neoadjuvant Therapy in Triple
Negative Breast Cancer
Prof.S.Loibl
(Clinical Oncologist -
Germany)
10:15 – 10:45 Break
10:45 – 11:45
Panel discussion:Which patients will have surgery at first?
Coordinator: Dr.P.Azimi Nejadan
Members: Dr.A.Joulaei, Dr.A.Rakhsha, Dr.H.Zham, Dr.GH.Razei,
Dr.F.Ziaei, Dr.M.Ariana, Dr.N.Nafisi, Dr.F.Taslimi, Dr.M.Kalantari,
Dr.H.Rezvani
11:45 - 13
Panel discussion:Triple negative metastatic patients.
Coordinator: Dr.H.R.Mirzaei
Members: Dr.M.Akhgari, Dr.H.Haji Zade Falah, Dr.SH.Dadgari,
Dr.A.Hojat, Dr.S.Sayad. Dr.R.Anbiyaei, Dr.P.Hajian, Dr.M.Tabaraei,
Dr.A.Movafagh
25
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
time title Coordinator Wednesday 20 Feb 2019
16:30 – 17:30 Mammography Interpretation
Dr. Astani
time title Coordinator
Wednesday 20 Feb 2019 16 – 17:30
Breast surgery Prof.Akbari Prof.Benson
time title Coordinator
Thursday 21 Feb 2019 13 - 15
Chemotherapy Dr.Jafari
time title speaker
13 - 13:30 Use of the port in patients undergoing chemotherapy
and necessary care Ms.Zeynali
13:30 - 14 Chemotherapy in patients with liver and infectious
diseases Dr.P.Gorji
14 – 14:30 Chemotherapy in patients with heart disease, kidney
disease
Dr.T.Taheri Panah
14:30 - 15 Chemotherapy in elderly
patients Dr.A.Jafari
time title Coordinator Thursday 21 Feb 2019
11 – 12:30 Contouring of breast lymph
node Dr.S.Saedi
time title Coordinator
Thursday 21 Feb 2019 15:30 - 17
Sentinel lymph node Prof. Akbari
26 26
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
27
14th International Breast Cancer Congress
Scientific Program
20-22 Feb 2019, Tehran. Iran
Oral Presentation
14th International Breast Cancer Congress
28 28
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
First day
2019 February 20, Wednesday
SUBJECT AUTHOR/AUTHORS TIME CODE
Downregulation Of MICAL3 In
Breast Cancer
Mina Zafarpiran,
Mohammad Khalaj-kondori 9:05-9:10 R1-01
99mtc-HYNIC-(Tricine/EDDA)-
FROP Peptide For MCF-7
Breast Tumor Targeting And
Imaging
Sajjad Ahmadpour,
Zohreh Noaparast,
Seyed Mohammad Abedi,
Seyed Jalal Hosseinimehr
9:10-9:15 R1-02
Discordance Of HER2
Expression In Primary Breast
Cancer And Related Axillary
Lymph Node Metastasis
Azar Naimi , Bahar Saffar ,
Fereshteh Mohammadizadeh
9:15-9:20 R1-03
Specific Delivery Of ZHER2
Affibody-Conjugated Gold
Nanoparticles As
Radiosensitizer To HER2-
Overexpressing Malignant
Cells
Aminollah Pourshohod,
Mostafa Jamalan,
Majid Zeinali,
Alireza khairollah
9:20-9:25 R1-04
Gene Expression Profile Of
Circulating Tumor Cells In
Breast Cancer By RT-Q PCR
Armin Gharibi,
Masoud Sohrabi rad 9:25-9:30 R1-05
Relationship With
Investigation Of PTEN-Mir 127-
5p Breast Cancer In Women Of
Ardabil Province
Ramin Nouri ,
Morteza Hakimian ,
Sasan Talaneh
9:30-9:35 R1-06
Investigating The Association
Of A2256G Polymorphism Of
MDR1 Gene With Breast
Cancer In Women In Ardebil
Ramin Nouri,
Morteza Hakimian,
Sasan Talaneh
9:35-9:40 R1-07
A Survey On The Association Of
Mir520 Gene Polymorphism
With Breast Cancer In Women
In Urmia
Sasan Talaneh ,Ali Sedghiani-
Far ,Noshine Ansafi ,
masome abasi
9:40-9:45 R1-08
Investigation Of The Repeat Sequence Length Of CA Intron 1 Of GATA3 Gene With Breast
Cancer In Women Of West Azarbaijan Province
Sasan Talaneh, Ali Sedghiani-Far ,
Noshine Ansafi masome abasi
9:45-9:50 R1-09
29
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
The Investigation Of The
Relationship Between FGFR
Mutation G1138T And Breast
Cancer In West Azarbaijan
Province
Morteza Hakimian ,
Ramin Nouri, Sasan Talaneh
9:50-9:55 R1-10
Investigating The Relationship
Between SHBG G247E
Polymorphism And Breast
Cancer In Women In Urmia
Sasan Talaneh ,
Ali Sedghiani-Far ,
Noshine Ansafi ,
Ramin Noori ,
Morteza Hakimian
9:55-10:00 R1-10
Investigating The Relationship
Between The 206 A / T
Polymorphism Of VEGF Gene
And Breast Cancer In Women
Of West Azarbaijan Province
Sasan Talaneh,Zahra
Azad,Razieh Azad-e ,Ramin
Nouri, Morteza Hakimian
10:00-10:05 R1-11
Downregulation Of Differentiation Antagonizing
Long None Coding RNA (DANCR) And Its Cerna
Network Target Gene, CTNNB1, In Breast Cancer Tissues And
Adjacent Non-Neoplastic Tissues Of Iranian Turkish
Breast Cancer Patients
Zeynab Shaghaghi Torkdari, Mohammad Khalaj Kondori, Mohammad Ali Hosseinpour
Feizi, Vahid Montazeri
10:05-10:10 R1-12
Break 10:10-10:40
In Silico Design Of A Novel
Peptide Inhibitor Derivative Of
Pediocin CP2 Affecting Breast
Cancer
EnsiehsadatEmadi,
SomayehReiisi
10:50-10:55 R1-13
Study Of CYP1A1
Polymorphisms In Women
With Breast Cancer In East
Azarbaijan Province
Hamideh Mohammadzadeh
10:55-11:00 R1-14
Overexpression Of Mir-
191 Inhibits Doxorubicin
Induced Apoptosis In MCF7
Breast Cancer Cell Line
Shirin Eyvazi,
Vahideh Tarhriz
11:00-11:05 R1-15
Investigation On The Effect Of
Quercetin Suspended
Nanoparticles On Cancer Stem
Cell Breast Cancer
Fatemeh Eivaz Damerchi
Darsi, Hakimeh Zali, Saeed
Hesami Tackallou
11:05-11:10 R1-16
30 30
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
Overexpression Of Mir-
191 Down-Regulates P53 In
MCF7 Breast Cancer Cell Line
Shirin Eyvazi, Vahideh
Tarhriz 11:10-11:15 R1-17
Effect Of Bfgf Peptide
Antagonist On Mouse Model
Breast Tumor Through
ERK/MAPK And PI3K/AKT
Signaling Pathways
Mehrzad Jafarzadeh ,
Shahrazad Ghadiriyan ,
Mohsen Asghari ,
Mohammad Taghi Joghataei ,
Mohammad Hashemi
Bahremani,
Kazem Mousavizadeh
11:15-11:20 R1-18
Early Detection Of Breast
Cancer Using Circulating
Mirnas In Peripheral Blood
Marzieh Ahmadi, Hanieh
Sadeghi ,Aryan Kamal,
Bahareh Shayesteh Pour,
Hamid Gourabi ,Andreas
Keller, Mehdi Totonchi
11:20-11:25 R1-19
A Brief Description A Bout
Mirna And Breast Cancer
Maryam etemadi, samareh
gooshki 11:25-11:30 R1-20
Regulation Of BAX/BCL2 Gene
Expression In Metastatic
Breast Cancer By Docetaxel –
Loaded Human Serum Albumin
Nanoparticles
Marzieh Kordezangeneh,
Shiva Irani,
Reza Mirfakhraie,
Mehdi Esfandyari-Manesh,
Fatemeh Atyabi ,
Rassoul Dinarvand
11:30-11:35 R1-21
Comparative Proteomic
Analysis Of Breast Cancer
Tissue And The Adjacent
Normal Tissue In Iranian
Patients With HER2 Negative
Ductal Carcinoma Of Breast
Mayram Amiri-
Shoar,Masoumeh Hosseini,
Mitra Arianmanesh,
Reza Eghdam-Zamiri,
Shahrokh Attarian,
Ali Awsat Mellati
11:35-11:40 R1-22
Comparison Of The Addition Of
Vitamins A And E To The Drug
Diet Of Women With Breast
Cancer Prone To Intravenous
Thrombosis Under
Chemotherapy: Double-Blind
Clinical Trial
Dara Alvandfar,
Mohammad Reza Katani,
Nafiseh Arefi,
Abbasali Dorosti,
Majid Montazer
11:40-11:45 R1-23
Effect Of Gallic Acid On Human
Breast Cancer Cells In
Presence Of Low Level Laser
Irradiation
Zohreh Hoseinmardi,
Zahra Kianmehr,
Khatereh Khorsandi
11:45-11:50 R1-24
31
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
Cytotoxicity Of TPSF Small
Molecule On MCF-7 Breast
Cancer Cells In Hydrogel
Scaffold
Kiavash Hushmandi,
Saad Gooraninejad,
Elham Hoveizi,
Mohammad Reza Tabandeh
11:55-12:00 R1-26
The Effect Of Vitamin A On
MCF-7 Cell Viability
Ebrahim Rahmani
Moghadam, Leila Jafaripour,
Teimour Tabari,
Farid Hashemi,
Amirhossein Zabolian,
Amirhossein Milani,
Gholamhossein Darya
12:00-12:05 R1-27
Serum Level Of Colony
Stimulating Factors,
Granulocyte, Monocyte And
Granulocyte-Monocyte, In
Peripheral Blood Of Patients
With Breast Cancer
Zahra Faghih,
Parisa Karimzadeh,
Fatemeh Eghbali,
Somayeh Rezaeifard,
Mahboobeh Razmkhah
12:05-12:10 R1-28
Evaluation Of Bovine
Leukemia Virus Infection In
Human Breast Tissue
Mohaddeseh Khalilian,
Seyed Masoud Hosseini,
Omid Madadgar
12:10-12:15 R1-29
Identification Of Novel Single
Chain Fragment (Scfv)
Antibody Against CD24, A New
Molecular Marker In Breast
Cancer
Shirin Eyvazi,
Bahram Kazemi,
Mojgan Bandehpour,
Siavoush Dastmalchi
12:15-12:20 R1-30
In Silico Pertuzumab Antibody
Affinity Maturation To
Improve Breast Cancer
Immunotherapy
Shirin Eyvazi,
Zahra Payandeh 12:20-12:25 R1-31
The Relationship Between
Resilience With Self-
Compassion, Social Support
And Sense Of Belonging In
Women With Breast Cancer
Saeedeh Alizadeh,
Shahriar Khanahmadi,
Abouali Vedadhir,
Samira Barjasteh
12:25-12:30 R1-32
Determinants Of Breast Cancer
Screening By Mammography In
Women Referred To Health
Centers Of Urmia, Iran.
Fatemeh Moghaddam
Tabrizi, Sakineh
Vahdati, Shahriar
Khanahmadi,
Samira Barjasteh
12:30-12:35 R1-33
32 32
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
The Effect Of Family-Based
Intervention Program On
Managerial Self-Efficacy
Related To Chemotherapy
Symptoms In Iranian Patients
With Breast Cancer; A
Randomized Control Trial
Saeedeh Alizadeh,
Fatemeh Moghaddam
Tabrizi, Shahriar
Khanahmadi, Samira
Barjasteh
12:35-12:40 R1-34
The Effect Of Family-Based Intervention
On FOCUS Program On The Quality Of
Life In Patients With Breast Cancer
Undergoing Chemotherapy; A
Randomized Clinical Trial
Samira Barjasteh ,
Faraz Tayyar,
Amin Safaripour,
Shahriar Khanahmadi
12:40-12:45 R1-35
The Effect Of Breastfeeding
And Diabetes On Breast Cancer
In Women With Breast Cancer
Referring To Cancer Research
Center Of Shahid Beheshti
University During 2012-16
Mohadeseh Rahbar
,Farshid Aaliazar 12:45-12:50 R1-36
Forecasting And Discovering
Association Relations
Weighted Between The
Characteristics Of Breast
Cancer Patients
Seyed Mohammad Saleh
Hadavi, S.R.Khayami ,
Elham Nadimi 12:50-12:55 R1-37
Exploring Of Family Social
Support After Mastectomy In
Women Referring To Omid
Hospital In Mashhad In 2018
Seyyedeh Sara Afrazandeh,
Raheleh Rajabi,Maryam
Ebrahimi, FaribaAsadi
12:55-13:00 R1-38
Cardiovascular disease and
mortality after breast
cancer in postmenopausal
women: Results from the
Women's Health Initiative
Seyed Ehsan Asadi ,Anahita
Shabanian-Sodabe
Mohamadi ,Ahmad Rahime,
Faeze Mazareei
13:00-13:05 R1-39
The effect of lower limb
stretching exercises on
reducing the potential of
venous thrombosis in breast
cancer patients under
chemotherapy: Double-blind
clinical trial
Dara Alvandfar,
Mohammad Reza Katani,
Nafiseh Arefi, Abbasali
Dorosti, Majid Montazer
13:05-13:10 R1-40
33
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
Second day
2019 February 21 , Thursday SUBJECT AUTHOR/AUTHORS TIME CODE
Breast Cancer Survival and Reproductive Factors:
A Follow up Study on Parous Women with Breast Cancer in
Iran
Ghasem Yadegarfar, Somaye Momenian, Mohammad Esmaeil
Yadegarfar, Mohammad Esmaeil Akbari
14:30-14:35 R2-01
Relationship between Preeclampsia and Breast
Cancer : A case-control study Zohre Sheikhan 14:35-14:40 R2-02
Hand Massage + Bandage Massage Weekly Before Mastectomy Surgery on
Lymph Nerve: A Clinical Trial
Dara Alvandfar, Mohammad Reza Katani,
Nafiseh Arefi, Abbasali Dorosti, Majid Montazer
14:40-14:45 R2-03
Breast Reconstruction Surgery after
mastectomy:Inevitable Necessity
Seyyedeh Sara Afrazandeh, , Maryam Ebrahimi,
Raheleh Rajabi FaribaAsadi
14:45-14:50 R2-04
The Effectiveness of Religious-spiritual education on the self-efficacy of Women
with Breast Cancer
Farzane Nasiri, Zohre Keshavarz، Mohamadhasan
Davazdahemami, Saeed Karimkhani Zandi,
Malihe Nasiri
14:50-14:55 R2-05
The effect of counseling on self-efficacy in mastectomized
women: a randomized controlled trial
Monireh Hamed Biabayani, Mojgan Mirghafourvand,
Sakineh Mohammad-Alizadeh Charandabi
14:55-15:00 R2-06
Assessment of relationship between medication and estimated risk of breast
cancer using Gail model among
women in southeastern Iran, 2017-18
Hossein Ansari , Ali Yousefzadeh
15:00-15:05 R2-07
Survey Of Knowledge, Worry And Screening Behavior
Towards Breast Cancer Among Female Students Of Ahvaz Jundishapur University of Medical Sciences in 2018
Pouriya Darabiyan, Hajar Sadeghi, Ali Reza Rafi,
Zeinab Raiesifar, Maryam Ghanavati, Kourosh Zarea
15:05-15:10 R2-08
34 34
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
Investigating the Attention to Parameters of Environmental
Health Related to Breast Cancer
Zahra Aghalari , Somayeh Jafarian
15:10-15:15 R2-09
The association of chronic diseases with breast cancer in
Alzahra hospital of Tabriz
Raheleh Janani . Rogayeh Purreza,
Nahid Tahmasebpur, Maryam Vahidi
15:15-15:20 R2-10
Impact of Factors on recurrence of Patients with of breast cancer using Weibull
Cure Model
Fahimeh Ghasemi , Ali Akbar Rasekhi , Shahpar Haghighat
15:20-15:25 R2-11
C.novyi_NT: a promising approach to treat breast
cancer
Fatemeh Abedi Jafari, Asghar Abdoli ,
Reza Pilehchian, Neda Soleimani,
Seyed Masoud Hosseini
15:25-15:30 R2-12
Exploring of family social support after mastectomy in
women referring to Omid Hospital in Mashhad in 2018
Seyyedeh Sara Afrazandeh, Raheleh Rajabi,Maryam Ebrahimi,FaribaAsadi
15:30-15:35 R2-13
Effects of a saffron based syrup on fatigue in breast cancer patients: A double-blind randomized placebo-
controlled clinical trial
Ghazaleh Heydarirad, Hamidreza Mirzaei,
Reyhaneh Gharehgozlou, Shirin Fahim,
Parastoo Hajian
15:35-15:40 R2-14
Primary breast cancer with metastatic and non-
metastatic: Demographics and clinical features
Afsoon Taghavi , Gohar Mohammadi
15:40-15:45 R2-15
Apoptotic Effect of Glacium flavum extract on MCF-7
Cancer Cells
Ebrahim Rahmani Moghadam, Leila Jafaripour,
Reza jahangiri, Farid Hashemi, Gholamhossein
Darya, Amirhossein Milani, Amirhossein Zabolian.
15:45-15:50 R2-16
The Relationship Between Glutathione S Transferase Polymorphism And Breast Cancer In Women Of West
Azarbaijan Province
Sasan talaneh, Zahra azad kasb , noshin ensafi
15:50-15:55 R2-17
35
14th International Breast Cancer Congress
Oral Presentation
20-22 Feb 2019, Tehran. Iran
Poster Presentation 14th International Breast Cancer Congress
36 36
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
First day ( Unit 1 )
2019 February 20, Wednesday
SUBJECT AUTHOR TIME CODE
The combination of Coffee and
tamoxifen is effective against
breast cancer
Ghadiriyan Shahrazad,
Jafarzadeh Mehrzad ,
Mohammad Najafi
9:00-9:20 P1-01
Predictors of adopting the
breast cancer preventive
nutritional behaviors among
women of reproductive age
based on the Constructs of the
Bandura Social Cognitive Theory
Mohammad Hosein Taghdisi,
Tahereh Dehdari,
Alireza Dehnabi, Mitra Zarati
9:20-9:40 P1-02
Unmet Health needs and
Concerns of women with breast
cancer from the health care
system and health providers - a
qualitative study
Amin Safaripour,
Samira Barjasteh, Zohreh
khakbazan , Faraz Tayyar
9:40-10:00 P1-03
The effect of lower limb massage
with almond oil during
chemotherapy in women with
breast cancer: clinical trial
Dara Alvandfar,Mohammad
Reza Katani, Nafiseh Arefi,
Abbasali Dorosti, Majid
10:00-10:20 P1-04
Effectiveness of Acceptance and
Commitment therapy on the
Depression, Anxiety and Stress
among patients with breast
cancer
Mohammad Sadegh Sarizadeh
10:20-10:40 P1-05
The Incidence of Breast Cancer
in Iranian Women and Men; a
systematic review and meta-
analysis
Authors: Samira Beiranvand,
Kourosh Zarea, Parisa
Sheinijaberi
10:40-11:00 P1-06
Investigating Effective Factors
on Breast Self-examination
Behavior in Iranian Employed of
Medical Careers
Saeed Bashirian ,Majid Barati ,
Younes Mohammadi ,
Leila MoaddabShoar ,
Mitra Dogonchi
11:00-11:20 P1-07
37
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
First day ( Unit 2 )
2019 February 20 , WednesdaySUBJECT AUTHOR TIME CODE
Predictors of Quality of Life of Breast Cancer Patients
Fatemeh Mirzaei, Roghaiyeh Nourizadeh, Azizeh
Farshbaf-Khalili 9:00-9:20 P2-01
Mammography perceptions among women in an Iranian setting: A qualitative study
Mardi Afrouz, Refahi soheila, Madadzadeh Mitra
9:20-9:40 P2-02
The effect of counselling on breast cancer awareness in
Iranian rural women: a randomized controlled
clinical trial
Parvin Alizadeh Sabeg, Esmat Mehrabi, Roghaiyeh Nourizadeh,
Hamid Poursharifi, Saeed Mousavi
9:40-10:00 P2-03
Reconstruction of feminine identity: the strategies of
Iranian women with breast cancer for cope with body
image altered
Sharareh Zeighami mohammadi, Sima Mohammad Khan
Kermanshahi, Zohreh Vanaki10:00-10:20 P2-04
The Comparison of knowledge and practice of
women who referred to health centers in
Kermanshah with the same center's personnel in
regarding prevention of breast cancer in 2016
Vahab karamivand , Soroush maazinezhad
10:20-10:40 P2-05
Investigating the Survival Rate and Some Factors
Affecting Breast Cancer in Women
Arezoo Shayan , Batul Khodakarami,
Farkhondeh Jamshidi10:40-11:00 P2-06
The Effect of Spirituality on Quality of Life in Women with Breast Cancer: The
Role of Hope and Educational Attainment
Mobin Mohammadinezhad , Saeed Pahlevan Sharif, Rebecca H
Lehto, Mohammadreza Amiri, Ashraf Sadat Ahadzadeh, Hamid Sharif Nia, Ali Akbar Haghdoost ,
Fatemeh Khoshnava, Amir Hossein Goudarzian
11:00-11:20 P2-07
Assessment of different environmental factors for
Breast Cancer Among Women
Masoomeh asadi, Alieh afsharnia, shahin mazidi 11:20-11:40 P2-08
38 38
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
First day ( Unit 3 )
2019 February 20 , Wednesday SUBJECT AUTHOR TIME CODE
The Effect of a SMS-based Education Intervention on
Improving the Breast Cancer Preventive
Nutritional Behaviors Among Women Based on
the Constructs of the Bandura Social Cognitive
Theory
Mohammad Hosein Taghdisi, Tahereh Dehdari,
Alireza Dehnabi, Mitra Zarati
9:00-9:20 P3-01
Smoking and Breast Cancer: A Systematic
Review and Meta-Analysis of Iranian Studies
Bibi Hajar Zahmatkesh, Ahmad Khosravi, Afsaneh
Keramat, Nasrinossadat Alavi
, Reza Chaman
9:20-9:40 P3-02
The effect of education using “Problem Base
learning" method on the lifestyle of patients with
breast cancer
Hossein Feizi , Ronak Vakili Tajareh, Naser Rashadmanesh
9:40-10:00 P3-03
Effectiveness of Stress Coping Training on
Immune System and Pain Level in Patients with
Breast Cancer
Dr.M.Dorchin, Dr.A.K.Sheikhi, Dr.M.Akbari
10:00-10:20 P3-04
Dual role Transforming Growth Factor‑β in breast
cancer
Nahid Nafissi Shima Sadat Hashemi Madani
10:20-10:40 P3-05
The co-effect of shikonin and metformin on breast
cancer cell survival
Pegah Ghavidel, Zahra Nayeri, Mossa Gardaneh
10:40-11:00 P3-06
The effect of coping skills training on the quality of life among daughters of
mothers with breast cancer
Sedighe Khanjari , Mina mianji, Mitra Hakim
shooshtari, Hamid Haghani 11:00-11:20 P3-07
Incidence of breast cancer in Tehran province in
2014: results of the Iranian National
Population-based Registry
Dr. Gohar Mohammadi, Dr.Pardis Shojaei, Dr. Afsoon Taghvi,
11:20-11:40 P3-08
39
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
first day ( Unit 1 )
2019 February 20 , Wednesday SUBJECT AUTHOR TIME CODE
Frequency Of Sexual Dysfunction In Treated
Women Suffering Breast Cancer Refered To Surgical
Clinic S In Tonekabon
majid pouya paria bodduhi behruz
gholizadeh 14:30-14:45 P1-01
Early Detection Of Breast Cancer Through Liquid
Biopsy Using Deep Learning Technology
Amir Daaee, Mohammad Taheri, Soudeh Ghafouri-Fard, Hossein Mohammad-Rahimi,
Hosein Kazazi
14:45-15:00 P1-02
Using Machine Learning Techniques For Predicting
Breast Cancer
Mohammad Noorchenarboo, Mahboubeh Parsaeian
15:00-15:15 P1-03
Analysis Of Knowledge And Attitude Of Nursing Students Of Neyshabur Medical School About Breast Cancer In 2018.
Seyyedeh Sara Afrazandeh,Nadia
Naseri,Nazanin Naseri ,Fatemeh Bahador
15:15-15:30 P1-04
Available Status Screening Of Breast Cancer In Health
Services Providers Of Tabriz University Of Medical
Sciences In 2018
Masoumeh Ansari - Fatemeh Mohammadi - Aziza Behroozi
15:30-15:45 P1-05
Frequency Distribution Of Socio-Personal
Characteristics In Women Under Treatment For Breast
Cancer
Fahimeh Sehati Shafaee, Dr. Mojgan Mirghafourvand ,
Jalileh Amirzehni 15:45-16:00 P1-06
Comparing The Personality Subtypes And Attachment
Styles Of Women With Advanced Breast Cancer And
Breast Cancer Survivors: A Qualitative Study
Neda Shahvaroughi Farahani, Hossein Eskandari,
Ahmad Borjali 16:00-16:15 P1-07
40 40
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
first day ( Unit 2)
2019 February 20 , Wednesday SUBJECT AUTHOR TIME CODE
The Relationship Between Breastfeeding And Breast
Cancer
Mehdi Asadi ,Soodabeh Shahidsales, Masoumeh Nouri,
Mina Khani, Aghigh Ziaeemehr, Arash Arianpoor
14:30-14:45 P2-01
Effect Of Nurses' Support And Educational Care On
The Quality Of Life Of Women With Breast
Cancer Referring To Omid Hospital In Mashhad In
2018
Mehdi Asadi, Soodabeh Shahidsales, Masoumeh Nouri, Mina Khani Aghigh Ziaeemehr,
Arash Arianpoor
14:45-15:00 P2-02
Prevalence Of Sexual Dysfunction And
Relationship With Tamoxifen Among Women Of Reproductive Age With Breast Cancer In Bushehr
City
Rezvan Sohrabi Nejad , Hakimeh Vahed Parast, Razieh
Bagherzadeh, Tayebeh Gharibi, Farkhondeh
Mahboudi
15:00-15:15 P2-03
The Relationship Between Spiritual Health And Sleep
Quality In Adults With Diabetes
Mehri Bozorg Nejad
Fatemeh Mohaddes Ardebili 15:15-15:30 P2-04
Comparison Of The Use Of Varicose Socks With And
Without Lower Limb Massage In Susceptible
Women With Breast Cancer Undergoing
Chemotherapy: Clinical Trial
Dara Alvandfar1,Mohammad Reza Katani,2 Nafiseh Arefi3,
Abbasali Dorosti4, Majid Montazer5
15:30-15:45 P2-05
Passive Smoking And Risk Of Breast Cancer Among
Woman In Tonekabon City Maryam Avar 15:45-16:00 P2-06
41
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
first day ( Unit 3 )
2019 February 20 , Wednesday
SUBJECT AUTHOR TIME CODE
The Relation Of Socio-Personal Characteristics
With Subdomains Of Financial Problems Of
Women Under Treatment For Breast Cancer
Fahimeh Sehati Shafaee, Dr. Mojgan Mirghafourvand,
Jalileh Amirzehni 14:30-14:45 P3-01
Supportive Care Needs Of Iranian Breast Cancer
Patients
Fatemeh Mirzaei , Azizeh Farshbaf-Khalili Roghaiyeh Nourizadeh
14:45-15:00 P3-02
Mammography Perceptions Among Women In An Iranian Setting: A Qualitative Study
Mardi Afrouz, Refahi soheila Madadzadeh Mitra
15:00-15:15 P3-03
The Effect Of Spirituality Training In Group On Quality
Of Life And Body Image Caused By Chemotherapy In
Breast Cancer Patients
Nasrin Elahi, Safa Najafi: 15:15-15:30 P3-04
The Prevalence Of Rumination Disorder And
Some Related Factors Among Women With Breast Cancer
At The Age Of Fertility In Bushehr City
Rezvan Sohrabi Nejad, Hakimeh Vahed Parast,
Razieh Bagherzadeh, Tayebeh Gharibi,
Farkhondeh Mahboudi
15:30-15:45 P3-05
Evaluating Changes In Sexual Functioning Of Breast Cancer Women During The Phase Of
Radiotherapy
Golazin Bahiraei, Camelia Rohani
15:45-16:00 P3-06
Knowledge, Health Beliefs And Practice Of Isfahan City
Health Volunteers About Self Breast Examination: A Cross-
Sectional Study Based On Health Belief Model
Sanaz Nasiri Isfahani, Mohtasham Ghafari,
Naser Rajabi, Hamid Souri, Hussein Hatami
16:00-16:15 P3-07
42 42
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Second day (Unit 4)
2019 February 21 , Thursday
SUBJECT AUTHOR TIME CODE
Knowledge Practice Of Breast Self-Examination
Among Female Students In Torbat Heydarye
Universitys
Majid Hassanzadeh Sedighe Abbaspour, Zohre
Zandy.Hamideh yaghoby 14:30-14:45 P4-01
Knowledge Of Chemotherapy Induced Amenorrhea In Breast
Cancer
Majid Hassanzadeh SedigheA bbaspour, Zohre
Zandy.Hamideh yaghoby 14:45-15:00 P4-02
Risk Factors For Breast Cancer In Women 25 To 49
Years Case Control Study
Marzbani Behjat Taymoori Parvaneh Marzbani Behnaz
Nouri Bijan4 Shahabadi Sara 15:00-15:15 P4-03
Evidence Of Decreasing OAR (Lungs, Ribs, Skin)
Absorption Dose By Increasing The Number Of
Lumen In Breast Brachytherapy Applicators
With MCNP
Fatemeh Mahdavi 15:15-15:30 P4-04
Comparing Breast Cancer In The World And Iran, 2008-
2018 Yousef Bashiri 15:30-15:45 P4-05
Improving Soluble Expression Of A Single-
Chain Antibody Pertuzumab By Co-Expression Of
Chaperones
Amir Mirzapour Estabragh, Vajihe Akbari, Hamid Mir
Mohammad Sadeghi 15:45-16:00 P4-06
Investigating The Relationship Between The 206 A / T Polymorphism Of
VEGF Gene And Breast Cancer In Women Of West
Azarbaijan Province
Sasan Talaneh, Zahra Azad,Razieh Azad-Ramin
Nouri, Morteza Hakimian 16:00-16:15 P4-07
43
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Second day (Unit 5)
2019 February 21 , Thursday
SUBJECT AUTHOR TIME CODE
Central Memory CD8+ T Cells In Tumor Draining Lymph
Nodes Of Breast Cancer Patients
Yasmin Vahidi, Abdol-Rasoul Talei,
Abbas Ghaderi, Zahra Faghih 14:30-14:45 P5-01
The Germline Pathogenic Variants In A Patient With
Familial Squamous Cell Carcinoma Of Breast
Mina Amin, Elaheh Mahmoodi khaledi, Sina Narrei, Mehrdad Zeinalian
14:45-15:00 P5-02
The Relationship Between Psychological Symptoms
And Quality Of Life In Women With Breast Cancer
Bahare Sadat Nayeb-ol Sadri, Tabassom saeid par var
15:00-15:15 P5-03
Predictors Of Breast Self - Examination Among
Midwifery Students Using Health Belief Model
Taiebeh nekoee, Maryam monkashef
15:15-15:30 P5-04
Occupational Performance Problems In Women With
Breast Cancer
Majid Hassanzadeh Sedighe Abbaspour, Zohre
Zandy.Hamideh yaghoby 15:30-15:45 P5-05
Spatial Structure Of Breast Cancer Using Poisson
Generalized Linear Mixed Model In Iran (2004-9)
Mansour Rezaei, Abdullah Jalilian, Soodeh Shahsavari,
Behzad Mahaki , Maryam Veismoradi
15:45-16:00 P5-06
Quality Of Life In Patients With Breast Cancer And Its
Related Factors In Yazd City In 2015
Fereshteh Eidy, hosein fallahzade, mohammad forat yazdi, Maryam Rabie, fariba
Zare ,erfan javanmardi
16:00-16:15 P5-07
44 44
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Second day (Unit 6)
2019 February 21 , Thursday
SUBJECT AUTHOR TIME CODE
Monomethyl Auristatin E As A Potent Cytotoxic Small
Molecule For Development Of Antibody-Drug
Conjugates Against Breast Cancer
Meghdad Abdollahpour-Alitappeh, Zahra Keshtkaran, Mohammad Hossein karimi, Majid Lotfinia4 Esmaeil Kavi
14:30-14:45 P6-01
Cytotoxic Effects Of Nanoparticles Copolymer
Drug Carrier’s Quercetin On Breast Cancer Stem Cells
Rana Mohammad Taghi Kashi,
Hakimeh Zali,Saeed Hesami Tackallou
14:45-15:00 P6-02
Exploring Of Perceptions Of Iranian Women With Breast Cancer Regarding The Role
Of Spiritual Self-Care Activities In The Promotion
Of Hope
Maryam Sheikhpourkhani, Abbas Abbaszadeh, Fariba
Borhani and Maryam Rassouli 15:00-15:15 P6-03
The Relation Of Lymphedema And Activities
Of Daily Living In Women With Breast Cancer-Related
Lymphedema
Majid Hassanzadeh. Dr Dehghan.
SedigheA bbaspour, Zohre Zandy.Hamideh yaghoby
15:15-15:30 P6-04
Quality Of Life And Its Relation With Perceived
Stress And Self-Esteem In Women Under Breast
Cancer Treatment
Majid Hassanzadeh Sedighe Abbaspour, Zohre
Zandy.Hamideh yaghoby 15:30-15:45 P6-05
Illness Perceptions In Women With Breast Cancer
Fatemeh Mirzaei, Azizeh Farshbaf-Khalili , Roghaiyeh Nourizadeh
15:45-16:00 P6-06
Effectiveness Of Short-Term Psychotherapy Based On
Stress Management Training On The Control Of
Anger And Emotions In Patients With Breast Cancer
Ehsan Ebrahimi, Ali Taghinezhad, Mehri Alikhani
16:00-16:15 P6-07
45
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Third day (Unit 1)
2019 February 22 , FridaySUBJECT AUTHOR TIME CODE
The Relationship Of Health Belief And Breast Self-
Examination Among University Students In Torbat Heydareye
Majid Hassanzadeh . Dr Dehghan.
SedigheA bbaspour, Zohre Zandy.Hamideh
yaghoby
9:00-9:20 P1-01
Evaluation Of Anti- Cancer Properties Of Chamomile Extract In Breast Cancer Cell Line MCF-7
Batool Bonjari , Hamid Reza Rahimi , Reza
Assaran Darban 9:20-9:40 P1-02
The Combination Of Coffee And Tamoxifen Is Effective Against
Breast Cancer
Ghadiriyan Shahrazad, Jafarzadeh mehrzad,
Mohammad Najafi 9:40-10:00 P1-03
A Qualitative Study In Iranian Women With Breast Cancer
Sharareh Zeighami mohammadi,
Sima Mohammad Khan Kermanshahi, Zohreh Vanak
10:00-10:20 P1-04
The Effectiveness Of Religious-Spiritual Education On The Self-Efficacy Of Women With Breast
Cancer
Farzane Nasiri, Zohre Keshavarz, Mohamadhasan
Davazdahemami, Saeed Karimkhani Zandi ,
Malihe Nasiri
10:20-10:40 P1-05
Application Of PEN-3 Model In Training Breast Cancer
Screening Behaviors Among Female Teachers Of Isfahan
Elaheh Shoushtari Moghaddam,
Hossein Shahnazi, Akbar Hassanzadeh
10:40-11:00 P1-06
Caffeic Acid And Over Expression Of P21 In Breast Cancer Cells
(MCF-7)
Hamid Cheshomi, Mohammad
Hosseinzadeh Hesari, Gholam Hossein
Ghasemzadeh
11:00-11:20 P1-07
46 46
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Third day (Unit 2)
2019 February 22 , Friday
SUBJECT AUTHOR TIME CODE
Comparison Of Serum Levels Of Microrna-155 In Breast
Cancer Patients In Terms Of Progesterone Receptor And
Estrogen Receptor
Fatemeh Hosseini, Mojahed Vahid
pouresmaeil, Amir Amirabadi;
Amir Hossein Aalami, Mahdi Ghasemi Rad
9:00-9:20 P2-01
The Study Associations Of Haplotypes Of Xrcc3 Gene
With Risk Of Breast Cancer In Iranian Women Population
Milad Pezeshki, Jamshid Ansari
9:20-9:40 P2-02
Association Of Cdh1 And Tert Single Nucleotide
Polymorphisms With Susceptibility To Familial
Breast Cancer Risk
Mahsa Bagherpour, Kamelia Gharibzad ,
Hossein Rassi 9:40-10:00 P2-03
Overexpression Of Serum Microrna-140-3p In
Premenopausal Women With Newly Diagnosed Breast
Cancer
Nadia Heydari,
Novin Nikbakhsh, Farzin Sadeghi,
Nazila Farnoush, Soraya Khafri, Milad Bastami, Hadi Parsian
10:00-10:20 P2-04
In Silico Design Of A Novel Peptide Inhibitor Derivative
Of Pediocin Cp2 Affecting Breast Cancer
EnsiehsadatEmadi, SomayehReiisi
10:20-10:40 P2-05
Quantification Of Angiogenic Factors In Breast Cancer And
Assessment Of Their Clinic Pathological Correlations
Mahboobeh Razmkhah , Negin Rahmani , Parisa Karimzadeh, Somayeh Rezaeifard, Fatemeh
Eghbali, Zahra Faghih
10:40-11:00 P2-06
47
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
Third day (Unit 3)
2019 February 22 , FridaySUBJECT AUTHOR TIME CODE
Fer 1 Like Protein 4 (FER1L4) Long None Coding RNA And
RB1 Cerna Network Expression Analysis In Breast Cancer
Tissues And Adjacent Non-Cancerous Tissues Of Iranian
Turkish Breast Cancer Patients
Zeinab Shaghaghi Torkdari, Mohammad Khalaj Kondori, Mohammad Ali Hosseinpour
Feizi, Vahid Montazeri 9:00-9:20 P3-01
Investigating The Relationship Between The 206 A / T
Polymorphism Of VEGF Gene And Breast Cancer In Women Of West Azarbaijan Province
Sasan Talaneh, Zahra Azad, Razieh Azad, Ramin Nouri,
Morteza Hakimian 9:20-9:40 P3-02
Cloning And Expression Of Pcmv3-Noggin-GFP Spark In
Breast Cancer Cell Line, MCF-7
Aghvami Tehrani A, Latifi navid S, Zahri Sagha M 9:40-10:00 P3-03
Suppressor Of Cytokine Signaling (SOCS)Genes Are Downregulated In Breast
Cancer
Mohammad Taheri, Soudeh Ghafouri-Fard,
Naghmeh Abbasi, Hossein Mohammad-Rahimi
10:00-10:20 P3-04
Comparison Of Cytotoxicity Of Three Natural Phenolic
Compounds On MCF-7 Cell Line
Hamid Cheshomi, Mohammad Hosseinzadeh
Hesari 10:20-10:40 P3-05
Studying The Expression Of TCEB1 In Tumoral And
Marginal Tissues Of The People With Breast Cancer
Mahsa Tarighi, Mohammad Khalaj-kondoriMina
Zafarpiran10:40-11:00 P3-06
Effect Of Bfgf Peptide Antagonist On Mouse Model
Breast Tumor Through ERK/MAPK And PI3K/AKT
Signaling Pathways
Mehrzad Jafarzadeh , Shahrazad Ghadiriyan ,
Mohsen Asghari, Mohammad Taghi Joghataei ,
Mohammad Hashemi Bahremani, Kazem
Mousavizadeh
11:00-11:20 P3-07
48 48
14th International Breast Cancer Congress
Poster Presentation
20-22 Feb 2019, Tehran. Iran
49
4th International Cancer Congress
21-22 Feb 2019, Tehran. Iran
Oral Presentation
4th International GI Cancer Congress 21-22 Feb / Tehran / Iran
50
4th International GI Cancer Congress
21-22 Feb 2019, Tehran. Iran
Scientific Program
51
4th International Cancer Congress
21-22 Feb 2019, Tehran. Iran
Oral Presentation
Scientific Program
4th International GI Cancer Congress
52
4th International GI Cancer Congress
21-22 Feb 2019, Tehran. Iran
Scientific Program
First day Thursday, 21 Feb 2019
4th International Gastro Intestinal Cancer Congress (main hall)
Speaker Title Time Speaking code
Holly Quran & National Anthem of the Islamic Republic of Iran
7:50 – 8:00
Panel: Practical Solutions to Reduce the Financial Burden of Cancer
Panel Coordinator: Prof. M.E Akbari Panel members: Dr. I Harirchi (Surgeon), Dr. GH Jan
babaei (hematologist Oncologist), Dr. M R Vaez Mahdavi (Health sciences), Dr. A Ghanbari
Motlagh (radiotherapist oncologist), Dr. M R Zafar Ghandi (Surgeon), Dr. SH Haghighat (Epidemiologist), Dr. M Akbari (Health sciences),
Dr. P Hosseinpour (pathologist), Dr. A Norouzi (Health sciences), Mr. T Mouhebati (Health sciences),
Dr. H Souri (Epidemiologist), Dr. A Moradi(pathologist)
8:00 – 9:30
Prof. M.E Akbari (head of cancer
research center and congresses)
Welcoming Message 9:30 – 9:45
Dr. S Namaki (Minister of Health
and Medical Education)
Opening Notes 9:45 – 10:00
Appreciation of Honorable Prof. S A Malek Hoseini 10:00 – 10:30 Break 10:30 – 11:00
Chairmen: Dr. J Khoshnevis, Prof. SA Malek Hoseini, Dr. R Kianmanesh
Dr. R Kianmanesh (surgeon)
Neuroendocrine Pancreas Tumor 11:00 – 11:15 01-01
Dr. S Nikeghbalian (fellowship of liver
transplantation)
Modern Techniques in Surgery of Pancreas Tumors
11:15 – 11:30 01-02
Dr. B Ghavami (surgeon)
Pancreatic Surgery with Laparoscopy
11:30 – 11:45 01-03
Dr. S Hafezi Bakhtiari
(pathologist, UofT)
Whipple Specimen: a Pathologist Perspective
11:45 – 12:00 01-04
Dr. A Sadeghi (gastroenterologist)
The Role of Imaging in Pancreatic Cancer: Diagnosis and Staging
12:00 – 12:15 01-05
53 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Panel: Diagnosis and Treatment of Pancreatic Cancer Panel Coordinator: Dr. S Nikeghbalian
Panel members: Dr. R Kianmanesh (surgeon), Dr. N Mansour Moshtaghi (fellowship of cancer
surgery), Dr. B Kazeminejad (pathologist), Dr. Z Kamali (pathologist), Dr. M Boroumand (radiotherapist
oncologist), Dr. M Saneitaheri (radiologist), Dr. A Sadeghi (gastroenterologist), Dr. H Rezvani
(hematologist Oncologist), Dr. M Dehghani (liver surgeon)
12:15 - 13:30
Pray and Lunch 13:30 – 14:30 Chairmen: Dr. S R Mousavi (vascular surgeon), Dr. I Harirchi (cancer surgeon), Dr. R Malekzadeh (gastroenterologist), Dr. S Nikeghbalian (fellowship of liver
transplantation) Dr. R Kianmanesh
(surgeon) Liver Colon Metastasis/
Neuroendocrine Liver Tumor 14:30 – 14:45 01-06
Dr. B Salehi (gastroenterologist)
Diagnostic Technique for Residue of Liver Tumor
14:45 – 15:00 01-07
Dr. M Saberafsharian (pathologist)
Pathologic Categorization of Liver Tumors
15:00 – 15:15 01-08
Dr. M Abdolahad (Electrotechnical
Sergeon)
Metas-Chip, an Integrated System for Detecting the Metastasis in
Secondary Sites 15:15-15:30 01-09
Break 15:30 – 16:00 Panel: Diagnosis and Treatment of Liver Cancer
Panel Coordinator: Dr. R Kianmanesh Panel members: Dr. J Shakeri (fellowship of cancer
surgery), Dr. H Nemati (cancer surgeon), Dr. F Bidari (pathologist), Dr. SH Sabeti (pathologist), Dr. H R
Haghighatkhah (radiologist), Dr. N Zendehdel (gastroenterologist), Dr. M Sanei (radiotherapist
oncologist), Dr. B Sanei (fellowship of liver surgeon)
16:00 – 17:30
54
4th International GI Cancer Congress
21-22 Feb 2019, Tehran. Iran
Scientific Program
Second day Friday, 22 Feb 2019
4th International Gastro Intestinal Cancer Congress (main hall)
Speaker Title Time Speaking code Chairmen:
Dr. I Fazel, Dr. H Peirovi, Dr. H R Haghighat khah, Dr. A Bidari, Dr. H Attarian Dr. F Moradian
(fellowship of cancer surgery)
Epidemiology of Gastric Cancer
8:00 – 8:15 02-01
Prof. S A Malek Hoseini (transplantationist)
Important Aspects of Gastric Cancer Surgery
8:15 – 8:40 02-02
Dr. P Dehghan (radiologist) Radiologic Presentation in
Gastric Cancer 8:40 – 8:55 02-03
Dr. S Abdi (gastroenterologist)
Gastric Polyps 8:55 – 9:10 02-04
Dr. K Tulabi (surgeon) Laparoscopic Upper GI
Cancer 9:10- 9:30 02-05
Panel: Diagnosis and Treatment of Gastric Cancer Panel's Coordinator: Prof. S A Malek hoseini
Panel's members: Dr. F Moradian (fellowship of cancer surgery), Dr. H Hajizadeh fallah (pathologist),
Dr. A Mafi (radiotherapist oncologist), Dr. P Dehghan (radiologist), Dr. M Forutan (gastroenterologist),
Dr. M Houshiary (radiotherapist oncologist), Dr. S Hafezi Bakhtiari (GI pathologist, UofT),
M Dehghani (liver surgeon)
9:30 – 11:00
Break 11:00 – 11:30 Chairmen: Dr. M S fazeli (colorectal surgeon), Dr. A Afshar fard (surgeon),
Dr. M R Kalantarmotamedi (surgeon) Dr. M Saneitaheri
(radiologist) Radiology Status in
Diagnosis of Colon Tumors 11:30 – 11:50 02-06
Dr. SH Shahrokh (gastroenterologist)
Diagnosis Approach for Colon Cancer
11:50 – 12:10 02-07
Dr. M Mozafar (surgeon)
Treatment of Patients with Colon Cancer and
Aneurysm Aorta: do's and don'ts
12:10 – 12:30 02-08
Dr. S Hafezi Bakhtiari (GI pathologist, UofT)
Predictive and Prognostic Role of Some Pathology Findings in Colorectal
Cancer
12:30 – 12:45 02-09
55 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Dr. J Khoshnevis (surgeon)
Report of Surgery Results for Esophageal Cancer with
Oringer’s Technique in Shohada Tajrish Hospital
(25 Years)
12:45 – 13:00 02-10
Prayer and Lunch 13:00 – 14:00 Panel: Colon Cancer
Panel Coordinator: Dr. H R Zamani Panel members: Dr. B Ghavami (surgeon), Dr. M
Samsami (fellowship of cancer surgery), Dr. S Hafezi Bakhtiari
(GI pathologist, UofT), Dr. A yaghubi juibari (radiotherapist oncologist), Dr. S A Astani (radiolosist),
Dr. SH Shahrokh (gastroenterologist), Dr. F S Anaraki (colorectal surgeon)
14:00 – 15:30
Break 15:30 – 16:00 Panel: nutrition in cancer
Panel coordinator: Prof. M.E Akbari Panel members: Dr. S H Davoodi (nutritionist),
Dr. S Doaei (nutritionist), Dr. M Gholamalizaeh (Phd by research candidate), Dr. T Rezanistani (nutritionist),
Dr. N Khoshnevis (nutritionist), Dr. F Moradian (fellowship of cancer surgery), Dr. M Shadnoush
(nutritionist)
16:00 – 17:30
56
4th International GI Cancer Congress
21-22 Feb 2019, Tehran. Iran
Scientific Program
57 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Poster Presentation
4th International GI Cancer Congress
58 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 1 )
2019 February 21 ,Thursday
SUBJECT AUTHOR TIME CODE Existence Of Direct Correlation Between The Methylation Rate
Of Individual Cpgs Present In CYP1A1 Gene Cis-Acting
Element
Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N,
Mehraban P
11:00-11:15 P1-01
Relationship Between Global Incidence And Mortality Rates Of Stomach Cancer With The
Human Development Index: An Ecological Study
Mokhtar Soheylizad, Salman Khazaei
11:15-11:30 P1-02
The Effects Of Sodium Butyrate On The Expression Of LHX1
Gene As A Diagnostic Biomarker In HCT-116
Colorectal Cancer Cell Line
Mahsa ghiaghi, Flora Forouzesh
11:30-11:45 P1-03
Comparison Study Of The Methylation Moieties Of The
CYP1A1 Gene Promoter In Gastric Cancer Patients
Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N,
Mehraban P
11:45-12:00 P1-04
Showing The Difference Between Results Of Prognostic
Factors On Survival Of Colorectal Cancer Patients By Using A New Survival Analysis
Method
Haleh Aghamolaey, Ramin Aghamolaei, Ahmad
Reza Baghestani, Mohammad Esmaeil Akbari
12:00-12:15 P1-05
E Incidence And Risk Factors Of Venous Thromboembolism
In Iranian Inpatients With Inflammatory Bowel Disease: A Retrospective Cohort Study
Seyed Ehsan Asadi, Ali Bagheri-Elahe
Mohtasham, Ahmad Rahimi
12:15-12:30 P1-06
Circulating ghrelin levels and susceptibility to colorectal
cancer
Hamid Farahani, Kalhor Narges, Sara Afshari,
Fatemeh Mohammadi, Zahra Farahani
12:30-12:45 P1-07
59 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 2 )
2019 February 21 , Thursday
SUBJECT AUTHOR TIME CODE The Effect Of Opium On
Esophagus Cancer: A Systematic Review And Meta-Analysis
Azad Fatahi , Leili Tapak, Zahra
Cheraghi 11:00-11:15 P2-01
Role Of Mirnas As New Biomarkers In Diagnosis Of Hepatocellular Carcinoma
Amir Hossein Aalami
11:15-11:30 P2-02
Evaluation Of Cytotoxic Effect Of Betatrophin On Hepg2 Cell-Line
By MTT ASSAY
Nastaran Monzavi, Seyed Jalal Zargar, Nematollah
Gheibi 11:30-11:45 P2-03
Comparative Study Of Effect Of Cucurbitacin E, D And I On
Apoptotic Gene Expression In SW-480 Colon Cancer Cell Line
Mohammad Reza Sheikhi, Seyed Jalal Zargar
11:45-12:00 P2-04
Colon Complications In Pelvic Radiotherapy For Gynecological
Cancer, Case Series Study And Literature Review
Neda Nozari 12:00-12:15 P2-05
Silibinin Upregulates E-Cadherin Expression In MKN-45 Human
Gastric Cancer Cells
Ebrahim Faghihloo
12:15-12:30 P2-06
Evaluation of knowledge, sensitivity of Catching and
Perceived Severity of colorectal cancers in nursing students of
Neyshabour University of Medical Sciences in 2018
Seyyedeh Sara Afrazandeh,Nadia Naseri,
Nazanin Naseri
12:30-12:45 P2-07
60 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 3 )
2019 February 21 , Thursday SUBJECT AUTHOR TIME CODE
Investigating the expression of FGF19 gene as an effective gene
for the invasive behavior of cancer cells in patients with
colorectal cancer
Reza Yavari, Armin Gharibi 11:00-11:15 P3-01
Evaluation of Symptoms In Patients With Cancer Receiving
Chemotherapy From The Perspective Of Palliative Care In
Kashan, Iran, 2017
Fereshteh jalili, Negin Masoudi Alavi 11:15-11:30 P3-02
Evaluation of expression of miR-223 in serum of patients with a
gastric cancer undergoing surgery or chemotherapy
Amir Hossein Aalami, Vahid Pouresmaeil ,
Amir Amirabadi, Fatemeh Hosseini
Mojahed, Mahdi Ghasemi Rad
11:30-11:45 P3-03
Regulation of β-Catenin signaling by Gq class of G-proteins in colon
cancer cells
Nasim Forghani and S Mahmoud A Najafi 11:45-12:00 P3-04
Association of agricultural pesticides and gastric cancer
risk
Leili Sadeghi Amiri, Tiziano Verri, Ali Barzegar
12:00-12:15 P3-05
Investigation of the effects of Cucurbitacin D from Ecballium elaterium (L.) A. Rich on LC-3
gene expression in human gastric cancer cell line AGS
Naser Jafargholizadeh, Seyed Jalal Zargar
12:15-12:30 P3-06
Prevalence of H. pylori in patients with colorectal cancer; A systematic review and meta-
analysis
Afsoon Taghavi, Bahareh Hajikhani, Masoud
Dadashi, Zahra Jalili, Shahihn Bolouri, Fatemeh Fallah
12:30-12:45 P3-07
61 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 1 )
2019 February 21 ,Thursday
SUBJECT AUTHOR TIME CODE The Role Of Gαq Signaling On
Î’-Catenin Expression In HEK293T Cells
Nahid Khosronezhad , S Mahmoud A Najafi
14:30-14:45 P1-01
Mast Cell-Produced Prostaglandin D2 Prevents Colitis And Colitis-Related
Colon Cancer In Mice
Ali Nouri, Parisa Valipour, Fatemeh Heibati, Esfandiar
Heidarian
14:45-15:00 P1-02
Laparoscopic Jejunostomy: A Simple Valuable Procedure
Farzad Vaghef Davari ,Mohammad
Shirkhoda ,Rezvan Hashemi,Amirmohsen
Jalaeefar
15:00-15:15 P1-03
Targeted Cytotoxicity Of Bilayer Nanogel Containing Oxaliplatin On Colon Cancer
Cell Line (HT29) And Analysis Of BAX And Bcl2 Gene
Expression
Pooneh Movahedi Shad
15:15-15:30 P1-04
Antitumor Effect Of Aspirin On WNT Signalling Pathways In Colorectal Cancer Cell Line
Malihe Bagheri, AmirReza Hesari, Parisa ZiaSarabi,
Zahra Aghasi, Faezeh Ghasemi
15:30-15:45 P1-05
Study Of Methylation Status In APC Gene In Colorectal Cancer
Patient
Soheila Asoudeh, Fatemeh Asoudeh
15:45-16:00 P1-06
62 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 2 )
2019 February 21 ,Thursday
SUBJECT AUTHOR TIME CODE Epidemiological Study Of
Death Rate From Gastrointestinal Cancers In
Qazvin Province (2015)
Mina Shahsavari, Solmaz Farokhzad,
Dr Ardeshir Alizadeh Shahrivar, Tahereh Rezagoli
14:30-14:45 P2-01
The Study Of Rosa Canina L Extract On Bcl_2 And Bax
Genes Expression In Cancerous Cell Line AGS
Masoume Dastvar, Zahra deilami khiabani
14:45-15:00 P2-02
Experiences Of Children When Understand Cancer
Of Their Mothers: A Phenomenology Analysis
Manijeh Firoozi, 15:00-15:15 P2-03
The Effect Of Verbascoside On HIF-1α Expression As Valuable Metastasis And
Angiogenesis Factor In HT-29 Colon Cancer Cells
Danial Seyfia, Seyed Bahram Behzada, Mohammad Nabiunib,
Kazem Parivarc, Mohammad tahmasebc, Elaheh Aminic
15:15-15:30 P2-04
Evaluation Of Immunohistochemical
Expression Of Survivin And Its Correlation With -31G/C
Gene Polymorphism In Colorectal Cancer
Zahra Heidari ,Hamidreza MahmoudzadehSagheb,
AsiyehHakimi, Bita Moudi
15:30-15:45 P2-05
Overexpression Of Mir146a-5p, As A Novel
Prognostic Marker, Inhibits Migration Of Human HT-29 Colorectal Cancer Cells Via
Down-Regulating Metastasis-Related Genes
Expression
Saeed Noorolyai , Ahad Mokhtarzadeh,
Elham Baghbani, Amir Baghbanzadeh kojabad,
Behzad Baradaran
15:45-16:00 P2-06
63 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
First day ( Unit 3 )
2019 February 21 ,Thursday SUBJECT AUTHOR TIME CODE
Dietary Patterns And The Risk Of Colorectal Cancer
And Adenoma
Alireza Bahrami, Ehsan Hejazi,
Azita Hekmatdoost, Amir Sadeghi
14:30-14:45 P3-01
Bioinformatics Assessment Of The Targetome Signaling Pathways Hsa-Mir-544a And
Associated SNP Function (Rs12245) In People With
Colorectal Cancer
Afrooz Shekarchizadeh, Mansoureh Azadeh,
Atefeh Zamani
14:45-15:00 P3-02
Primary Sarcoma Of The Pancreas, A Case Report With
Review Of Literature
Dr.Norouzi Alireza, Dr.Taghipour Hamed, Dr.pouladi Yasamin
15:00-15:15 P3-03
GPC3 Expression At The Mrna Level In The Colorectal
Cancer
Sonia Azizpour, Razieh Ezati, Razieh Amini
15:15-15:30 P3-04
Correlation Of Lncrna PVT1 Upregulation With Advanced
Stages And Invasion In Esophageal Squamous Cell Carcinoma (ESCC) Patients.
Zahra roohinejad , Davood Sabour ,
Mohammad Shafiee , Shabbou Bahramian,
Reza Sahebi
15:30-15:45 P3-05
Factors Associated With Risk Of Colorectal Cancer
Recurrence Following Initial Treatment: A 10-Year Cohort
Study
Parisa Mohammadi, Fateme Sadat Miremad,
Mojtaba Keikha, Mostafa Dianatinasab
16:00-16:15 P3-06
64 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 4 )
2019 February 22 ,Friday
SUBJECT AUTHOR TIME CODE Determination The Effects Of Genistein On Caspase-3
And P-38 Mapk Gene Expression In Gastric Cancer AGS Cell Lines.
Neda Ghasemkhani, Iraj Khodadadi,
Gholamreza Shafiei 9:00-9:20 P4-01
Hypoxia-Inducible Factor 1-Alpha, (Hif-1A), Tend To Over-Expressed In High
Tumor Stage In Esophageal Squamous Cell Carcinoma
(ESCC)
Shabbou Bahramian, Reza Sahebi,
Zahra roohinejad
Mohammad Shafiee
9:20-9:40 P4-02
Identification Of A Novel Mutation In Mitochondrial CO2 Gene In Patients With
Familial Adenomatous Polyposis (FAP)
Zahra Shaker Ardakani, Mohammad Mehdi
Heidari,Mehri Khatami
9:40-10:00 P4-03
The Effect Of Spiritual Counseling On Depression Of Gastric Cancer Patients
Maryam Nasari
10:00-10:20 P4-04
Determine The Survival Rate Of Esophageal Cancer
In Northern Iran: A Systematic Review And
Meta-Analysis
Ahmad Vahednasiri, Morteza Atayi,
Ehsan Aliasghari 10:20-10:40 P4-05
The Role Of Mir-146a-5p And CXCR4 In
Tumorigenesis Of Colorectal Cancer Cells
Reyhaneh Afshar Khamseh, Masoumeh Fakhr Taha,
Arash Javeri
10:40-11:00 P4-06
Epidemiology Of Gastrointestinal Cancers In
Cities Covered By Arak University Of Medical
Sciences: Cross-Sectional Study In 2009 And 2014
Pari Mirshafiei, Javad Nazari, Bahar Shahmohammadi,
Mohsen Farahani, Saeed Amini
11:00-11:20 P4-07
65 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 5 )
2019 February 22 , FridaySUBJECT AUTHOR TIME CODE
Investigating The Scattering Of Stomach
Cancer In Iran
Ehsan Aliasghari, Morteza Atayi,
Ahmad Vahednasiri 9:00-9:20 P5-01
EGFR Inhibitor Resistance In Colorectal Cancer
Haniyeh Bashi zadeh Fakhar, Hakimeh Zali,
Shabnam Jeibouei, Nazanin Ghasemi
9:20-9:40 P5-02
DNA Methylation Regulated Microrna-200b
In Colorectal Polyp And Cancer Tissues In Iranian
Population
Shabnam Tavangarroosta, Vahid Aliasghari, sanaz savabkar ,
Ehsan Nazemalhosseini Mojarad
9:40-10:00 P5-03
Methylation Of CDH11is An Independent
Prognostic Biomarker For Gastric Cancer Patients
Shirin Eyvazi, Vahideh Tarhriz,
Amir Mahdi Khamaneh, Bita Sepehri
10:00-10:20 P5-04
A Survey On Epha5 Methylation Status In
Gastric Adenocarcinoma Patients
Shirin Eyvazi, Vahideh Tarhriz,
Amir Mahdi Khamaneh, Bita Sepehri
10:20-10:40 P5-05
Effects Of Metformin In Combination Of 5-
Fluorouracil On Cell Viability Assay In Gasteric
Cancer Cell Lines
Sahar Moazenrad , Pardis Cheraghali
10:40-11:00 P5-06
Study The Anticancer Effect Of Herbal Carcumin
Extract On HER-2 Expression In Gastric
Adenocarcinoma Cells
Sahar Zarrabi, Zahra Deilami Khiabani
11:00-11:20 P5-07
66 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 6 )
2019 February 22 , Friday
SUBJECT AUTHOR TIME CODE
Characterization Of Gastric Microbiota In Gastric Cancer
Patients
Shirin Eyvazi, Vahideh Tarhriz,
Amir Mahdi Khamaneh, Bita Sepehri
9:00-9:20 P6-01
In Vitro Analysis Of The Anticancer Properties Of
Cobra Venom In Colorectal Cancer Cell Line
Mahdi Shekarabi, Kamran Pooshang Bagheri,
Delavar Shahbazzadeh
9:20-9:40 P6-02
Clinicopathological Features And Prognosis Of Elderly Gastric Cancer Patients In West Azarbaijan Province
Hesami, R , Entezar Mahdi, R
Khalkhali, H , Esnaashari,O 9:40-10:00 P6-03
Sodium Butyrate Inhibited The Growth Of Colorectal Cancer SW480 Cell Lines.
Arghavan Sheikh , Flora Forouzesh, Mahdi Shabani,
Shahram Zarrabian
10:00-10:20 P6-04
The Study Of The Curcumine Extract On Htert Gene Expression In Gastric
Adenocarcinoma Cells (AGS)
Hamed Boostaniyan , Zahra Deilami Khiabani
10:20-10:40 P6-05
Administration Of Intravenous Infliximab For
Prevention Of Peritoneal Adhesions
Formation In Rats
Saman Nikeghbalian, Homeira Vafaei, Farid Moradian, Kourosh Kazemi, Nader Tanideh,
Leila Shayan, Zahra Nikeghbalian
10:40-11:00 P6-06
Effects Of Curcumin And Ethanolic Turmeric Extract
On Growth And Proliferation Of Cancerous Cells (4T1)
Hooman Yazdanpour, Gholamali Jelodar,
Saeed Nazifi, Mohammad
Movafaghizadeh
11:00-11:20 P6-07
67 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 1 )
2019 February 22 , Friday SUBJECT AUTHOR TIME CODE
Calculation Of Absorbed Dose Rate In The Esophagus, Stomach
And Pancreas By The Mammosite Applicator In Breast
Cancer Brachytherapy With MCNP
Fatemeh Mahdavi 14:30-14:45 P1-01
Assessment Bioinformatics Of Targetum Signaling Pathways
Hsa-Mir-3605-3p And Its Related SNP Function (Rs12977)
In People With Gastric Cancer
Aliasghar Falahiyan Javani, Kamran Ghaedi,
Mohammad Fazilati, Mansoure Azadeh,
Atefeh Zamani
14:45-15:00 P1-02
Study Gastric Cancer In The World And Iran During 2008 To
2018 Yousef Bashiri
15:00-15:15 P1-03
The Effect Of Curcumine Extract On E-Cadherin Gene Expression
In Adenocarcinoma Gastric Cancer Cells
Ali Habashi, Zahra Deilami Khiabani 15:15-15:30 P1-04
Human Epidermal Growth Factor Receptor-2 Assessment
In Cancerous And Precancerous Lesions Of The Stomach In
Presence Of Helicobacter Pylori
Zahra Heidari, Hamidreza
Mahmoudzadeh-Sagheb, Nadia Sheibak, Mehran
Panahi, Setareh Jami
15:30-15:45 P1-05
Investigation Of Five Year Survival Rate And Epidemiologic
Features In Patients With Gastrointestinal Cancers In West
Azerbijan Province
Ahmad Reza Shamshiri, Rabee Hesami,
Koorosh Etemad,Rashid Ramezani,Ali Ghanbari
Motlagh, Kamran Dehghan, Bahram Nemati,
Rasool Entezar Mahdi
15:45-16:00 P1-06
68 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Identification and Evaluation of Plasma microRNAs and lncRNAs
as Novel Diagnostic and Prognostic Biomarkers in
Pancreatic Ductal Adenocarcinoma Based on
Bioinformatics Methods
Mohammad Amin Mahmanzar ,
Binazir khanabadi, Reza Mahmanzar,
Shaghayegh Jamshidizadeh ,
Saeedeh sadat Beheshti Shirazi,
Farzaneh Shalileh , Elmira Sadat Tabatabaei, Simin Rezaei, Seyad Ali
Karimifard, Ehsan Nazemalhosseini-
Mojarad, Amir Sadeghi , Hamid Asadzadeh
Aghdaei
16:00-16:15 P1-07
69 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 2 ) 2019 February 22 ,Friday
SUBJECT AUTHOR TIME CODE
Survival Analysis Of Patients With Metastatic Gastric Cancer
Using Cox Regression Model
Touba narimani moghadam,
Moghaddameh Mirzaee, Abbas Bahrampour,
Yunes Jahani, Mehdi Hayatbakhsh
Abbasi, Yousef bashiri
14:30-14:45 P2-01
A Comparative Analysis Of Gene Expression Profile In Liver And Esophagus Cancer By Expressed
Sequence Tags
Mahboobeh Ramezani , Fatemeh Shamsabadi,
Morteza Oladnabi 14:45-15:00 P2--02
NPAS2 Gene Expression In Gastric Cancer
Negar Haghpanah, Zivar Salehi,
Mohammadjavad Mehdipour, Soheila Talesh
Sasani, Keyvan Aminian
15:00-15:15 P2--03
Prevalence Of Helicobacter Pylori Vaca Genotypes In
Paraffin-Embedded Biopsy Samples Prepared From Patients With Upper Gastrointestinal (GI)
Carcinoma
M.Esmaeillou, A. Bahadori,KH. Maleki Chollou, P.
Abedi, Hamed Hassanpour, L. Hasheminejad, N.
samsami,
15:15-15:30 P2--04
Up-Regulation Of Lncrna PVT1 Correlates With Advanced Stages
And Invasion In ESCC Patients.
Zahra roohinejad, Davood Sabour, Mohammad
Shafiee, Shabbou Bahramian, Fatemeh T.
Shamsabadi, Reza Sahebi
15:30-15:45 P2--05
Study The Effect Of Curcumin Extract On Beta-Catenin
Expression In Adenocarcinoma Gastric Cancer Cells
Sanaz Ansarifar, Zahra Deilami Khiabani,
15:45-16:00 P2--06
Evaluation the panel of Plasma circularRNA as Novel
Biomarkers in cholangiocarcinoma Based on
Bioinformatics Methods
Binazir Khanabadi, Mohammad Amin
Mahmanzar, Reza Mahmanzar,
Helia Mojahed Yazdi, Asma Laleh, Elahe Daskar
Abkenar , Mahsa Mousakhan
Bakhtiari, Parnian Jabbari, Ehsan Nazemalhosseini-Mojarad, Amir Sadeghi,
Hamid Asadzadeh Aghdaei
16:00-16:15 P2--07
70 21-22 Feb 2019, Tehran. Iran
4th International GI Cancer Congress
Poster Presentation
Second day ( Unit 3 )
2019 February 22 , Friday SUBJECT AUTHOR TIME CODE
Sodium Butyrate Increased The Expression Of Mir-21 In
Human Colorectal Cancer HCT-116 Cell Line.
Parastoo mohammadi, Flora Forouzesh, Fatemeh
Kouhkan kahangi 14:30-14:45 P3-01
Expected Nausea Related To Chemotherapy Induced
Nausea In Cancer Patients
Zahra Khalili, Mahnaz Khatiban, Mahnaz Moghadari koosha
14:45-15:00 P3-02
The Quality Of Life Of People With Gastrointestinal
Ostomy In Iran
Shadie Kanani
15:00-15:15 P3-03
P16ink4a Immunohistochemical
Expression In Colorectal Adenocarcinoma Compared
To Adenomatous And Normal Tissue Samples
Zahra Heidari , Hamidreza
Mahmoudzadeh Sagheb , Enam Alhagh Charkhat
Gorgich
15:15-15:30 P3-04
Immunohistochemical Expression Of Survivin In
Gastric Cancer And Precancerous Lesions Of The
Stomach
Setareh Jami, Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb,
Mehran Panahi, Bita Moudi
15:30-15:45 P3-05
Overexpression Of Let-7e Enhances The
Radiosensitivity Of Colorectal Cancer Cells By Directly
Targeting IGF-1R
Pouria samadi, Saeid Afshar,
Rezvan Najafi, Abdolazim Sedighi
Pashaki, Razieh Amini, Ali Mahdavinezhad, Massoud Saidijam
15:45-16:00 P3-06
71
NOTE: ............................................................................................................................................... ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. .............................................................................................................................................................
72
............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. .............................................................................................................................................................